USPTO serial 79260161
GENETIS
Reviewed by CopyMark Law Group
Reg. 5893943Status 709
- Filing date
- Status date
- Registration date
- Oct 29, 2019
- Examiner
- KIDWELL WALKER, JACLYN NOEMI
- Law office
- TMO LAW OFFICE 113
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GENETIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Vaccines for human or veterinary use; vaccines for human or veterinary, therapeutic or prophylactic use, based on lentiviral vectors; chemical, biological, pharmaceutical products and preparations for therapeutic, prophylactic, medical, pharmaceutical and veterinary use; chemical reagents for therapeutic, prophylactic, medical, pharmaceutical and veterinary use; chemical-pharmaceutical products for therapeutic, prophylactic, medical, pharmaceutical and veterinary use | SECTION 71 - CANCELLED | — |
| 042 | Scientific research and development services for medical, therapeutic, pharmaceutical, veterinary and biological purposes, in the therapeutic or prophylactic vaccination field based on lentiviruses; research and development of new biological and pharmaceutical products for therapeutic, medical and veterinary use, in the therapeutic or prophylactic vaccination field based on lentiviral vectors and immunotherapy; bacteriological research services; virology research; infectious disease research, oncology research, clinical trials of vaccines; research in the field of diagnostic and therapeutic products for the treatment of infectious diseases; research in the field of diagnostic and therapeutic products for the treatment of viral diseases and cancer | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 15, 2026 | C71T | CANCELLED SECTION 71 | — |
| Jun 19, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 16, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 1, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 1, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 28, 2019 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Oct 29, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 23, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 13, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 7, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 7, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 24, 2019 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 8, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 20, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 14, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 10, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 6, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |